Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EUDA Health Holdings (EUDA) Non-Current Assets (2021 - 2025)

Historic Non-Current Assets for Health Holdings (EUDA) over the last 5 years, with Q2 2025 value amounting to -$1.3 million.

  • Health Holdings' Non-Current Assets fell 2367.35% to -$1.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$3.8 million, marking a year-over-year decrease of 67466.72%. This contributed to the annual value of -$762876.0 for FY2024, which is 545.1% down from last year.
  • Per Health Holdings' latest filing, its Non-Current Assets stood at -$1.3 million for Q2 2025, which was down 2367.35% from -$762876.0 recorded in Q4 2024.
  • Health Holdings' 5-year Non-Current Assets high stood at $3.6 million for Q4 2021, and its period low was -$1.3 million during Q2 2025.
  • For the 5-year period, Health Holdings' Non-Current Assets averaged around $210343.9, with its median value being -$60439.5 (2022).
  • The largest annual percentage gain for Health Holdings' Non-Current Assets in the last 5 years was 545.1% (2024), contrasted with its biggest fall of 27424.45% (2024).
  • Health Holdings' Non-Current Assets (Quarter) stood at $3.6 million in 2021, then tumbled by 83.48% to $602562.0 in 2022, then tumbled by 220.06% to -$723441.0 in 2023, then fell by 5.45% to -$762876.0 in 2024, then crashed by 71.25% to -$1.3 million in 2025.
  • Its Non-Current Assets stands at -$1.3 million for Q2 2025, versus -$762876.0 for Q4 2024 and -$1.1 million for Q2 2024.